Concepedia
Statistics
Publications
7
Citations
175
H-Index
Active since
2014
Affiliations
Ichnos Sciences (United States)(Current)
Glenmark Pharmaceuticals (Switzerland)
University of Oxford
Nantes Université
Glenmark Pharmaceuticals (India)
Julie Macoin is an author at Ichnos Sciences (United States) specializing in immunology, cancer immunology, and cancer immunotherapy.
Publications per year
2014–2024
Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis
Barbara Rewerska, Lawrence Sher, Sady Alpizar et al. · Journal of Allergy and Clinical Immunology Global · 2023 · 44 citations · Full text
Life Sciences, Dermatology, Immunology +13
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells
Laura Carretero-Iglesia, O. Hall, Jérémy Berret et al. · Nature Cancer · 2024 · 36 citations · Full text
Life Sciences, Immunology, Oncology +17
A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies
Caroline Breton, Aimable Nahimana, Dominique Aubry et al. · Journal of Hematology & Oncology · 2014 · 32 citations · Full text
Life Sciences, Immunology, Oncology +15
Pre-clinical characterization of ISB 1342, a CD38xCD3 T-cell engager for relapsed/refractory multiple myeloma
Blandine Pouleau, Carole Estoppey, Perrine Suere et al. · Blood · 2023 · 20 citations · Full text
Medicine, Hematology, Immunology +11
ISB 1342: A first-in-class CD38 T cell engager for the treatment of relapsed refractory multiple myeloma.
Marie‐Agnès Doucey, Blandine Pouleau, Carole Estoppey et al. · Journal of Clinical Oncology · 2021 · 17 citations
Medicine, Immunology, Pharmacology +17
1–5 of 7